ArticleTrials2020

Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.

Qing-Juan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.